{"id":13713,"date":"2018-07-14T14:20:29","date_gmt":"2018-07-14T12:20:29","guid":{"rendered":"http:\/\/www.onkologie-luebeck.de\/page\/?page_id=13713"},"modified":"2018-07-17T13:22:45","modified_gmt":"2018-07-17T11:22:45","slug":"dr-med-michael-paulsen","status":"publish","type":"page","link":"https:\/\/www.onkologie-luebeck.de\/page\/dr-med-michael-paulsen\/","title":{"rendered":"Dr. med. Michael Paulsen"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n\t

Portrait Dr. med. Michael Paulsen<\/h2>\n<\/div>
\n

Mitgliedschaften<\/h3>\n

Deutsche Gesellschaften
\n
<\/div>
\nDKG (Deutsche Krebsgesellschaft)
\nDGHO (Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Onkologie)<\/h6>\n
<\/h6>\n
<\/h6>\n
<\/h6>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
Europ\u00e4ische Gesellschaften
\n
<\/div>
\nESMO (European Society for Medical Oncology)<\/h6>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n

Fremdsprachen<\/h3>\n

Englisch<\/h6>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n

Ausbildung und Studium<\/h3>\n

1997 – 2004 Studium der Humanmedizin an der medizinischen Universit\u00e4t zu L\u00fcbeck
\n2000 Doktorand am Institut f\u00fcr Immunologie und Transfusionsmedizin
\n2004 Approbation als Arzt
\n2009 Erlangung der medizinischen Doktorw\u00fcrde mit experimentellen Arbeiten zu plasmazytoiden dendritischen Zellen<\/h6>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n

Klinischer Werdegang<\/h3>\n

2004 Arzt im Praktikum, Medizinische Klinik I, UKSH Campus L\u00fcbeck
\n2004-2011 Assistenzarzt, Medizinische Klinik I, UKSH Campus L\u00fcbeck
\nseit 2005 Pr\u00fcfarzt f\u00fcr diverse klinische Studien
\n2011 Anerkennung zum Facharzt f\u00fcr Innere Medizin
\nseit 2011 Funktionsoberarzt in der Abteilung f\u00fcr H\u00e4mato-Onkologie, Med. Klinik I, UKSH Campus L\u00fcbeck
\n10\/12 Wechsel in die L\u00fcbecker onkologische Schwerpunktpraxis
\n2014 Schwerpunktbezeichnung internistische H\u00e4matologie-Onkologie<\/h6>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/pages\/13713"}],"collection":[{"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/comments?post=13713"}],"version-history":[{"count":2,"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/pages\/13713\/revisions"}],"predecessor-version":[{"id":13861,"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/pages\/13713\/revisions\/13861"}],"wp:attachment":[{"href":"https:\/\/www.onkologie-luebeck.de\/page\/wp-json\/wp\/v2\/media?parent=13713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}